The human microbiome plays a critical role in our health, influencing everything from disease development to treatment responses.
Boehringer Ingelheim unveils mid-stage win for glucagon/GLP-1 candidate for MASH, kindling PhIII plans
Boehringer Ingelheim said on Monday that its “double G” metabolic dysfunction-associated steatohepatitis (MASH) drug delivered positive topline results in a Phase II trial. The company